Editorials Target cardiovascular risk rather than cholesterol concentration BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7110 (Published 27 November 2013) Cite this as: BMJ 2013;347:f7110 Article Related content Metrics Responses Peer review Related articles Analysis Shifting views on lipid lowering therapy Published: 28 July 2010; BMJ 341 doi:10.1136/bmj.c3531 Letter Target treatment benefit rather than risk or cholesterol concentration Published: 06 January 2014; BMJ 348 doi:10.1136/bmj.g10 See more Instrumental variable meta-analysis of aggregated randomized drug trial data for evaluating proposed target mechanisms BMJ February 25, 2021, 372 n346; DOI: https://doi.org/10.1136/bmj.n346 US abortions: Nine in 10 laws on access since 2017 increased restrictions, study finds BMJ February 24, 2021, 372 n542; DOI: https://doi.org/10.1136/bmj.n542 Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study BMJ February 10, 2021, 372 n102; DOI: https://doi.org/10.1136/bmj.n102 How Joe Biden plans to heal American healthcare BMJ February 03, 2021, 372 n176; DOI: https://doi.org/10.1136/bmj.n176 Covid-19: Moderna plans booster doses to counter variants BMJ January 26, 2021, 372 n232; DOI: https://doi.org/10.1136/bmj.n232 Cited by... Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statinsAbstract Fulltext PDF General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental studyAbstract Fulltext PDF Target treatment benefit rather than risk or cholesterol concentrationAbstract Fulltext PDF
